Through the European DTx Policy Coalition, the Digital Therapeutics Alliance and Healthware Group, as the official knowledge partner, have been actively engaging stakeholders and representatives from Ministries of Health, national trade associations, and European trade associations. Their collective efforts aim to establish comprehensive best practice frameworks for the utilization of digital medical devices (DMD), including digital therapeutics (DTx).
“Since its inception, Healthware has been focused on assisting life science companies in communicating, connecting, and building innovative solutions which enable better healthcare. Whether it’s new ways to market innovative drugs or digital solutions, fostering the growth of the ecosystem through thought leadership, or building ground-breaking patient solutions, our focus has always been built on a clear vision of Future Health. I’m proud of the work our team has done in collaboration with the DTA to help support the adoption and access of DTx globally thru the development of this valuable resource,” said Roberto Ascione, CEO at Healthware Group.